ESR2 and ovarian cancer: A recent report by Ciucci et al. described an association between nuclear ERβ1 staining and low tumour grade in 95 patients with ovarian cancer suggesting the subcellular location of ERβ isoforms may influence their functional role within breast cancer cells [41].